Talc mediates angiostasis in malignant pleural effusions via endostatin induction
Open Access
- 24 January 2007
- journal article
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 29 (4), 761-769
- https://doi.org/10.1183/09031936.00061606
Abstract
Talc remains the most effective sclerosing agent for pleurodesis. However, its mechanism of action in resolving pleural malignant disease remains unclear. The present study evaluated the angiogenic balance in the pleural space in patients with malignant pleural effusions (MPE) following talc insufflation. Patient pleural fluid samples were collected both before and after talc insufflation. The ability of pleural mesothelial cells (PMC) and malignant mesothelioma cells (MMC) to produce endostatin in vitro was compared. The biological effects of pleural fluids and conditioned media from talc-activated PMC on endothelial cells were evaluated by performing proliferation, invasion, tube formation and apoptosis assays. Pleural fluids from patients with MPE who received thoracoscopic talc insufflation contained significantly higher levels of endostatin (median 16.75 ng·mL−1) compared with pre-talc instillation (1.06 ng·mL−1). Talc-activated PMC released significantly greater amounts of endostatin (mean±sem 1052.39±38.66 pg·mL−1) when compared with a MMC line (134.73±8.72 pg·mL−1). In conlusion, talc alters the angiogenic balance in the pleural space from a biologically active and angiogenic environment to an angiostatic milieu. Functional improvement following talc poudrage in patients with malignant pleural effusions may, in part, reflect these alterations in the pleural space.Keywords
This publication has 29 references indexed in Scilit:
- Effektivität und zugrunde liegende Mechanismen der Talkumpleurodese bei malignem PleuraergussPneumologie, 2006
- Nuclear Factor-κB Affects Tumor Progression in a Mouse Model of Malignant Pleural EffusionAmerican Journal of Respiratory Cell and Molecular Biology, 2006
- Management of malignant pleural effusionsCurrent Opinion in HIV and AIDS, 2005
- Management of Recurrent Malignant Pleural Effusion with Chemical PleurodesisSurgery Today, 2005
- Alternative widely available, inexpensive agents for pleurodesisCurrent Opinion in Pulmonary Medicine, 2005
- Distribution of talc suspension during treatment of malignant pleural effusion with talc pleurodesisLung Cancer, 2002
- Management of malignant pleural effusionsEuropean Respiratory Journal, 2001
- Pleural Fluid pH as a Predictor of Survival for Patients With Malignant Pleural EffusionsChest, 2000
- Talc Pleurodesis for the Treatment of Pneumothorax and Pleural EffusionChest, 1994
- Chemical Pleurodesis for Malignant Pleural EffusionsAnnals of Internal Medicine, 1994